Robert Doebele

Robert Doebele

Company: Rain Therapeutics

Job title: Chief Scientific Officer


Panel Discussion: Addressing the Shortcomings of Developing NSCLC-Targeted Therapies 8:50 am

Patient population response differences and how to overcome these What design elements are most optimal to achieve clinical benefit? The push to early disease: what will this entail? How can the mechanism of action be predicted for each patient and thus inform dosing strategies?Read more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.